SynAct Pharma AB
STO:SYNACT
Cash Flow Statement
Cash Flow Statement
SynAct Pharma AB
| Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | |||||||||||||||||
| Net Income |
(77)
|
(85)
|
(96)
|
(101)
|
(106)
|
(142)
|
(159)
|
(164)
|
(224)
|
(192)
|
(168)
|
(160)
|
(90)
|
(92)
|
(104)
|
(115)
|
|
| Depreciation & Amortization |
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
75
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
|
| Stock-Based Compensation |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
8
|
0
|
0
|
0
|
10
|
0
|
0
|
0
|
|
| Other Non-Cash Items |
0
|
0
|
1
|
1
|
(0)
|
1
|
7
|
10
|
10
|
95
|
92
|
90
|
10
|
3
|
(0)
|
(1)
|
|
| Cash Taxes Paid |
(5)
|
(5)
|
(5)
|
(5)
|
(8)
|
(8)
|
(8)
|
(8)
|
(8)
|
(8)
|
(8)
|
(8)
|
(8)
|
0
|
0
|
0
|
|
| Cash Interest Paid |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
0
|
0
|
1
|
1
|
1
|
2
|
2
|
2
|
|
| Change in Working Capital |
12
|
13
|
3
|
(15)
|
(13)
|
9
|
23
|
52
|
39
|
16
|
(7)
|
(21)
|
(10)
|
(17)
|
15
|
24
|
|
| Cash from Operating Activities |
(65)
N/A
|
(72)
-10%
|
(92)
-29%
|
(116)
-25%
|
(118)
-2%
|
(131)
-11%
|
(129)
+2%
|
(102)
+21%
|
(100)
+2%
|
(81)
+19%
|
(82)
-2%
|
(92)
-11%
|
(89)
+3%
|
(107)
-20%
|
(89)
+16%
|
(91)
-2%
|
|
| Investing Cash Flow | |||||||||||||||||
| Other Items |
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash from Investing Activities |
(0)
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
+1 250%
|
0
+874%
|
0
+50%
|
0
+1%
|
0
-7%
|
0
-64%
|
0
-99%
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
|
| Financing Cash Flow | |||||||||||||||||
| Net Issuance of Common Stock |
80
|
0
|
0
|
0
|
229
|
0
|
0
|
0
|
59
|
0
|
0
|
0
|
94
|
0
|
0
|
0
|
|
| Net Issuance of Debt |
(0)
|
0
|
0
|
0
|
(1)
|
0
|
0
|
0
|
(1)
|
0
|
0
|
0
|
(1)
|
0
|
0
|
0
|
|
| Other |
(6)
|
(0)
|
125
|
125
|
(27)
|
201
|
75
|
75
|
(5)
|
54
|
102
|
102
|
(6)
|
107
|
96
|
131
|
|
| Cash from Financing Activities |
74
N/A
|
(0)
N/A
|
125
N/A
|
125
0%
|
201
+61%
|
201
0%
|
75
-62%
|
75
+0%
|
54
-28%
|
54
+0%
|
102
+88%
|
102
+0%
|
87
-14%
|
107
+23%
|
96
-11%
|
131
+37%
|
|
| Change in Cash | |||||||||||||||||
| Effect of Foreign Exchange Rates |
0
|
(0)
|
2
|
1
|
1
|
1
|
1
|
0
|
(0)
|
0
|
(1)
|
(0)
|
1
|
(1)
|
(0)
|
(0)
|
|
| Net Change in Cash |
9
N/A
|
(72)
N/A
|
34
N/A
|
10
-69%
|
84
+703%
|
71
-15%
|
(52)
N/A
|
(26)
+50%
|
(46)
-76%
|
(27)
+42%
|
18
N/A
|
10
-48%
|
(1)
N/A
|
(0)
+67%
|
6
N/A
|
39
+548%
|
|
| Free Cash Flow | |||||||||||||||||
| Free Cash Flow |
(65)
N/A
|
(72)
-10%
|
(92)
-29%
|
(116)
-25%
|
(118)
-2%
|
(131)
-11%
|
(129)
+2%
|
(102)
+21%
|
(100)
+2%
|
(81)
+19%
|
(82)
-2%
|
(92)
-11%
|
(89)
+3%
|
(107)
-20%
|
(89)
+16%
|
(91)
-2%
|
|